Clinical trial
A Study of Tarlatamab for People With Prostate Cancer
NCT07111507
Study timeline
Study start (actual)2025-07-31Date precision: day
Registry last updated2026-08-31
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Metastatic Prostate Cancerunresolved
Interventions
TarlatamabDRUG · verified · RxNorm: tarlatamab
Sponsors & collaborators
Memorial Sloan Kettering Cancer Centerlead sponsor
Amgencollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07111507 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.